In the stratified analyses according to cancer type, high KLF4 expression indicated better prognosis in patients with GC, HCC, PDAC and CRC, with a pooled HR of 0.59 (95% CI: 0.53–0.65, P < 0.001) for OS (Fig. 4A). Here, KLF4 is linked to hepatocellular carcinoma.